Gilead Sciences Inc. (GILD) Social Stream



Gilead Sciences Inc. (GILD): $63.15

1.12 (-1.74%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add GILD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#1 of 349

in industry

GILEAD SCIENCES INC (GILD) Price Targets From Analysts

Use the tables below to see what analysts covering GILEAD SCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 17 $100 $63 $78.5 $84.48 -7.08%
2021-11-19 18 $100 $63 $79.428 $84.48 -5.98%
2021-12-07 18 $100 $63 $79.266 $84.48 -6.17%
2021-12-14 19 $100 $63 $78.812 $84.48 -6.71%
2021-12-22 19 $100 $63 $79.125 $84.48 -6.34%
2022-01-07 18 $100 $63 $79.25 $84.48 -6.19%
2022-01-10 17 $100 $72 $80.714 $84.48 -4.46%
2022-01-25 17 $100 $72 $80.571 $84.48 -4.63%
2022-02-01 18 $100 $72 $80.571 $84.48 -4.63%
2022-02-02 18 $100 $71 $79.714 $84.48 -5.64%
2022-02-03 18 $100 $69 $78.928 $84.48 -6.57%
2022-02-18 18 $90 $69 $78.214 $84.48 -7.42%
2022-03-07 18 $90 $65 $77.5 $84.48 -8.26%
2022-03-16 18 $90 $65 $77.142 $84.48 -8.69%
2022-04-04 15 $90 $65 $75.5 $84.48 -10.63%
2022-04-12 15 $90 $63 $75.083 $84.48 -11.12%
2022-04-17 15 $90 $63 $74.75 $84.48 -11.52%
2022-04-29 15 $90 $63 $74.083 $84.48 -12.31%
2022-05-14 15 $90 $63 $74.166 $84.48 -12.21%
2022-05-16 15 $90 $63 $73.833 $84.48 -12.6%
2022-06-05 16 $90 $63 $72.769 $84.48 -13.86%
2022-08-03 17 $90 $65 $72.857 $84.48 -13.76%
2022-08-04 17 $90 $65 $72.923 $84.48 -13.68%
2022-08-14 17 $90 $65 $72.571 $84.48 -14.1%
2022-09-07 17 $90 $65 $72.785 $84.48 -13.84%
2022-09-17 16 $90 $65 $73.785 $84.48 -12.66%
2022-10-04 17 $90 $65 $74.357 $84.48 -11.98%
2022-10-21 17 $90 $60 $73.8 $84.48 -12.64%
2022-10-26 16 $90 $60 $74.2 $84.48 -12.17%
2022-10-28 16 $91 $60 $75.2 $84.48 -10.98%
2022-10-31 18 $96 $60 $77.733 $84.48 -7.99%
2022-11-07 18 $96 $68 $81.733 $84.48 -3.25%
2022-11-08 19 $96 $27 $78.937 $84.48 -6.56%
2022-11-28 19 $96 $27 $79.562 $84.48 -5.82%
2022-12-01 18 $105 $27 $81 $84.48 -4.12%
2022-12-12 19 $105 $27 $81 $84.48 -4.12%
2022-12-21 19 $105 $27 $81.5 $84.48 -3.53%
2023-01-03 19 $105 $27 $83.812 $84.48 -0.79%
2023-01-09 19 $105 $27 $84.312 $84.48 -0.2%
2023-01-22 19 $111 $27 $84.75 $84.48 0.32%
2023-01-23 19 $111 $27 $85.687 $84.48 1.43%
2023-01-27 19 $111 $27 $86.125 $84.48 1.95%
2023-02-03 18 $111 $27 $86.125 $84.48 1.95%
2023-02-06 18 $115 $27 $87.5 $84.48 3.57%
2023-02-08 18 $115 $27 $87.058 $84.48 3.05%
2023-02-13 18 $115 $27 $87.352 $84.48 3.4%
2023-02-24 18 $115 $72 $91.705 $84.48 8.55%
2023-04-06 17 $115 $72 $90.375 $84.48 6.98%
2023-04-21 17 $115 $72 $90.625 $84.48 7.27%
2023-04-28 17 $115 $72 $90.687 $84.48 7.35%
2023-05-01 18 $115 $72 $90.75 $84.48 7.42%
2023-05-15 18 $115 $72 $91.647 $84.48 8.48%
2023-05-16 18 $115 $72 $91.647 $84.48 8.48%
2023-07-11 18 $115 $80 $93.294 $84.48 10.43%
2023-07-17 18 $115 $80 $93.117 $84.48 10.22%
2023-07-24 18 $115 $80 $92.529 $84.48 9.53%
2023-07-25 18 $115 $80 $92.235 $84.48 9.18%
2023-08-04 18 $115 $80 $92.176 $84.48 9.11%
2023-08-07 18 $115 $80 $91.47 $84.48 8.27%
2023-09-06 18 $115 $71 $90.333 $84.48 6.93%
2023-09-07 18 $115 $71 $90.333 $84.48 6.93%
2023-10-11 18 $115 $71 $90.722 $84.48 7.39%
2023-11-08 18 $115 $71 $90.5 $84.48 7.13%
2023-11-09 19 $115 $71 $90.888 $84.48 7.59%
2023-11-15 19 $115 $71 $90.052 $84.48 6.6%
2023-12-12 19 $115 $71 $89.684 $84.48 6.16%
2023-12-29 19 $115 $71 $89.473 $84.48 5.91%

The Trend in the Analyst Price Target


Over the past 26 months, GILD's average price target has gone up $10.97.

GILD reports an average of 13.68% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-16 18 115 72 91.647 78.32 17.02%
2023-09-06 18 115 71 90.333 74.24 21.68%
2023-09-28 18 115 71 90.722 75.42 20.29%
2023-11-15 19 115 71 90.052 75.04 20.01%
2023-11-27 19 115 71 89.684 74.92 19.71%

GILD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.95 10 0 9 0 0 19

The Trend in the Broker Recommendations


GILD's average broker recommendation rating improved by 0.32 over the prior 19 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GILD as an investment opportunity.

  • In terms of how GILEAD SCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 6745.85% of that group.
  • GILD has a higher upside potential (average analyst target price relative to current price) than 941.24% of Pharmaceutical Products stocks.
  • In terms of how GILEAD SCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 6395.33% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, GILEAD SCIENCES INC's variance in analysts' estimates is lower than -2426.7% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GILEAD SCIENCES INC are BIIB, AMGN, and TAK.

Make investment decisions regarding GILD using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!